Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
American Journal of Hematology|January 5, 2017
The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donorsRonit Yerushalmi, Noga Shem-Tov, Ivetta Danylesko, et al.
Leukemia & Lymphoma|May 27, 2004
Rituximab in a patient with acute renal failure due to B-cell lymphomatous infiltration of the kidneysMargarita Tokar, Boris Rogachev, Itai Levi, et al.
Leukemia & Lymphoma|February 23, 2011
Adults requiring cord blood transplants but have insufficient cell doses from a single cord blood unit can receive two units with successful engraftment kinetics similar to those of children receiving a single unitGal Goldstein, Ronit Elhasid, Bella Bielorai, et al.
Harefuah|October 2, 2003
[Iron-deficiency anemia related to ancylostoma duodenale infection among Ethiopian immigrants to Israel]Itai Levi, Nava Gaspar, Klaris Riesenberg, et al.
International Journal of Fertility and Women'S Medicine|June 15, 2007
Do we need routine complete blood count following vaginal delivery?Shir Dar, Ilana Shoham Vardi, Gershon Holcberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2017
Isolated Extramedullary Relapse of Acute Leukemia after Allogeneic Stem Cell Transplantation: Different Kinetics and Better Prognosis than Systemic RelapseNoga Shem-Tov, Francesco Saraceni, Ivetta Danylesko, et al.
Acta Haematologica|August 26, 2015
Plerixafor (Mozobil): A Stem Cell-Mobilizing Agent for Transplantation in Lymphoma Patients Predicted to Be Poor Mobilizers - A Pilot StudyIvetta Danylesko, Rina Sareli, Nira Varda-Bloom, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2015
Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic SyndromesIvetta Danylesko, Rina Sareli, Nira Bloom-Varda, et al.
Haematologica|December 7, 2022
Second hematopoietic stem cell transplantation as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndromes after a first transplantationYaara Yerushalmi, Noga Shem-Tov, Ivetta Danylesko, et al.
Acta Haematologica|June 8, 2021
Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell TransplantationIvetta Danylesko, Jonathan Canaani, Avichai Shimoni, et al.
Pageof 7